| Literature DB >> 24740733 |
Agnieszka Wiertel-Krawczuk1, Juliusz Huber, Magdalena Wojtysiak, Wojciech Golusiński, Piotr Pieńkowski, Paweł Golusiński.
Abstract
Parotid gland tumor surgery sometimes leads to facial nerve paralysis. Malignant more than benign tumors determine nerve function preoperatively, while postoperative observations based on clinical, histological and neurophysiological studies have not been reported in detail. The aims of this pilot study were evaluation and correlations of histological properties of tumor (its size and location) and clinical and neurophysiological assessment of facial nerve function pre- and post-operatively (1 and 6 months). Comparative studies included 17 patients with benign (n = 13) and malignant (n = 4) tumors. Clinical assessment was based on House-Brackmann scale (H-B), neurophysiological diagnostics included facial electroneurography [ENG, compound muscle action potential (CMAP)], mimetic muscle electromyography (EMG) and blink-reflex examinations (BR). Mainly grade I of H-B was recorded both pre- (n = 13) and post-operatively (n = 12) in patients with small (1.5-2.4 cm) benign tumors located in superficial lobes. Patients with medium size (2.5-3.4 cm) malignant tumors in both lobes were scored at grade I (n = 2) and III (n = 2) pre- and mainly VI (n = 4) post-operatively. CMAP amplitudes after stimulation of mandibular marginal branch were reduced at about 25 % in patients with benign tumors after surgery. In the cases of malignant tumors CMAPs were not recorded following stimulation of any branch. A similar trend was found for BR results. H-B and ENG results revealed positive correlations between the type of tumor and surgery with facial nerve function. Neurophysiological studies detected clinically silent facial nerve neuropathy of mandibular marginal branch in postoperative period. Needle EMG, ENG and BR examinations allow for the evaluation of face muscles reinnervation and facial nerve regeneration.Entities:
Mesh:
Year: 2014 PMID: 24740733 PMCID: PMC4372688 DOI: 10.1007/s00405-014-3032-4
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Results of histopathological studies and the data on tumor size, their location and type of applied surgery in patients divided in two groups
| Tumor types | All patients ( | ||
|---|---|---|---|
| I. Benign tumors | |||
| Mixed (pleomorphic adenoma) | 9 | ||
| Warthin’s (adenolymphoma) | 3 | ||
| Myoepithelioma | 1 | ||
| II. Malignant tumors | |||
| Malignant melanoma | 1 | ||
| Myeloid sarcoma | 1 | ||
| Carcinoma ex pleomorphic adenoma (pT4apN2bM0) | 1 | ||
| Salivary duct carcinoma (pT1cN0M0) | 1 | ||
Fig. 1Example of modified Blair’s approach during parotid gland tumor removal
Fig. 2Locations of surface stimulation and recording electrodes during CMAP examinations: A from frontal (a) and orbicularis oris (a) muscles and blink-reflex bilateral recordings; B from orbicularis oculi muscles in one of the healthy volunteers
Data on House–Brackmann scale evaluation in healthy subjects and in patients on the symptomatic side at three periods of observation
| Examined group | Control group | All patients | Patients with benign tumor | Patients with malignant tumor | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| H–B scale | 1st period | 2nd period | 3rd period | 1st period | 2nd period | 3rd period | 1st period | 2nd period | 3rd period | |
| I | 21 | 15 | 12 | 12 | 13 | 12 | 12 | 2 | 0 | 0 |
| II | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| III | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | |
| IV | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | |
| V | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| VI | 0 | 4 | 4 | 0 | 1 | 0 | 0 | 3 | 4 | |
H–B scale: I normal function, II slight dysfunction, III moderate dysfunction, IV moderately severe dysfunction, V severe dysfunction, VI total dysfunction
1st, 2nd, 3rd, periods of observation (1st before surgery, 2nd 1 month after surgery, 3rd 6 months after surgery)
Fig. 3Changes of CMAPs parameters at three periods of observation (1st blue line, 2nd red line, 3rd green line) recorded from frontal (a) and orbicularis oris (b) muscles in one of patients with benign (A) and malignant (B) tumors
Differences in parameters of recorded CMAP potentials in the group of patients with benign tumors at certain periods of observations
| Recorded muscle | Patients with benign tumors 1st vs. 2nd observation ( | Patients with benign tumors 2nd vs. 3rd observation ( | ||
|---|---|---|---|---|
| Symptomatic side | Asymptomatic side | Symptomatic side | Asymptomatic side | |
| CMAP amplitude (mV) | ||||
| Frontal muscle | 0.674 | 0.625 | 0.529 | 0.477 |
| Orbicularis oris muscle | 0.05*↑ | 0.937 | 0.168 | 0.906 |
| CMAP latency (ms) | ||||
| Frontal muscle | 0.695 | 0.009*↓ | 0.722 | 0.266 |
| Orbicularis oris muscle | 0.224 | 0.382 | 0.248 | 0.953 |
| CMAP standardized latency (ms/cm) | ||||
| Frontal muscle | 0.760 | 0.314 | 0.154 | 0.036*↑ |
| Orbicularis oris muscle | 0.721 | 0.894 | 0.147 | 0.086 |
Significant differences found at p ≤ 0.05 are marked with asterisks (*). Arrows indicate increase↑ or decrease↓ of analyzed parameters
Fig. 4Changes of mean values of CMAP amplitudes recorded from orbicularis oris muscles in patients with benign and malignant tumors at three periods of observations
Fig. 5Examples of blink-reflex recordings from symptomatic (A) and asymptomatic (B) side in one of patients with benign tumor at three (1–3) periods of observation
Fig. 6Examples of CMAP recordings: A at three periods of observation (1st blue line, 2nd red line, 3rd green line) and B needle EMG recordings from orbicularis oris muscle in one of patients with benign tumor proving the regeneration and reinnervation processes
Data on denervation potentials in face muscles at rest during needle EMG recordings at subsequent periods of observations in 17 patients
| Observation periods | 1st period | 2nd period | 3rd period | |||
|---|---|---|---|---|---|---|
| Patients groups | Frontal muscle | Orbicularis oris muscle | Frontal muscle | Orbicularis oris muscle | Frontal muscle | Orbicularis oris muscle |
| Benign tumors | − 0/13 | − 0/13 | + 1/13 | + 1/13 | + 1/13 | + 1/13 |
| Malignant tumors | + 2/4 | + 2/4 | + 4/4 | + 4/4 | + 4/4 | + 4/4 |
For denervation “activity” “+”present, “−” absent
Spearman’s rank correlations (r s) of test results and tumor characteristics as well as types of surgeries obtained on the affected side in all patients at three stages of observation
| All patients | ||||||
|---|---|---|---|---|---|---|
| Periods of observation and parameter | 1st period | 2nd period | 3rd period | |||
|
|
|
|
|
|
| |
| ENG (1–3 score) | ||||||
| Tumor size (1–3 score) | 0.347 | 0.158 | Not compared | Not compared | Not compared | Not compared |
| ENG (1–3 score) | ||||||
| Tumor type (I–II) |
|
| Not compared | Not compared | Not compared | Not compared |
| ENG (1–3 score) | ||||||
| Surgery type (1–3) | Not compared | Not compared | 0.481 |
| Not compared | Not compared |
| H–B scale (I–VI) | ||||||
| ENG (1–3 score) |
|
|
|
|
|
|
| BR score (1–3) | ||||||
| ENG (1–3 score) | 0.425 | 0.079 |
|
|
|
|
For ENG and BR scores: 1, normal transmission; 2, mild disturbances in transmission (all parameters recorded but different from normatives) 3-severe disturbances in transmission (signs or potentials not recorded). Abbreviations are the same as in Tables 1 and 2. Italicized values indicate significant results with different power
p < 0.05 has been assumed for rank correlation as statistically significant (values in bold)